CHRIS MARCELLUS: Open Payments
NPI 1336871904 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,352 in 23 payments from 8 companies in 2025. Trend: 2023 $849 · 2024 $3,042 · 2025 $2,352
Food & beverage: $2,352
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $948 |
| Gilead Sciences, Inc. | 5 | $532 |
| Phathom Pharmaceuticals, Inc. | 2 | $238 |
| Janssen Biotech, Inc. | 3 | $147 |
| EVOKE PHARMA, INC. | 1 | $125 |
| Ardelyx, Inc. | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $113 |
Products named: SKYRIZI, VOQUEZNA, RINVOQ, TREMFYA, GIMOTI, IBSRELA, ZENPEP, Epclusa.
Industry payments across TN — which companies pay providers there.
